Ukugqamiswa okubalulekile komcimbi ukuthi ubambiswano lwamasu olumemezelwe ngesikhathi sengqungquthela. I-Hilllgene Biopharma, i-CDMO eholayo (ukuthuthukiswa kwenkontileka kanye nenhlangano yokukhiqiza) enakekela izidakamizwa zokwelapha amaseli, ukusayina izivumelwano ezintathu zamasu, kusiza ukuzibophezela kwazo ekususweni nasenkambisweni.
Ukubambisana kokuqala kwasungulwa nge-TCCX Therapeutics (TCCX Therapeutics Co, Ltd), inkampani eyaziwayo kwisizinda se-cell and gene Therapy Domain. Lokhu kusebenzisana kuhlose ukushayela kwasendaweni yokwelashwa kweseli futhi kwandise ukufinyelela kwayo kuzwelonke nakwamanye amazwe. Ngokuhlanganisa ubuchwepheshe babo nezinsizakusebenza, iHillgene Biopharma kanye nezokwelapha ze-TCRX zilungele ukusheshisa ukuthuthukiswa kanye nokulethwa kokusika - iseli eliseceleni - Iseli elisekelwe.
Enye into eyaziwayo yakhiwa ngoShanghai Nk Cellech Co, Ltd, umdlali ovelele embonini yokwelashwa kwamaselula. Lokhu kusebenzisa imali amakhulu ezinkampanini zombili ukuqhubekisela phambili ukuthuthukiswa kwe-NK cell - Izindlela zokwelapha ezisekelwe, ukuvula izindlela ezintsha zokwelashwa kwezifo eziyinselele. Ukubambisana kukhombisa ukuzibophezela kukaHilgene Biopharma ekwandiseni iphothifoliyo yabo nokubhekana nezidingo zezokwelapha ezingenakuvinjwa ngobambiswano lwamasu.
Okokugcina, uHillene Biopharma wajoyina amabutho ngeSuzhou vdo biotech Co, Ltd vdo biotech Co, Ltd, umhlinzeki oholayo wezinto ezibalulekile nemishini yomkhakha wezokwelapha amaselula. Lokhu kusebenzisana kuhlose ukuthuthukisa amandla obuchwepheshe futhi kuqinisekiswe ukuhlinzekwa okuzinzile kwezinto ezibucayi zokukhula okusheshayo nokuzinzile komkhakha. Ngokusebenzisana ngokuhlangene, lezi zinkampani zombili ziqhubekela phambili kokwenziwa kwasendaweni kanye nentuthuko yokwelashwa kwamaseli eChina nangale.
Kuyo yonke ingqungquthela, ubuchwepheshe nokunikezelwa kweHillgene Biopharma njenge-CDMO kuvezwe ngokuvelele. Ukugxila kwabo ekunikezeni izinsizakalo eziphelele ekuthuthukisweni kwezidakamizwa kanye nokukhiqiza izidakamizwa kwavunywa kabanzi. Njengomlingani othembekile wezinkampani ezidinga ukwesekwa okukhethekile, iHillene Biopharma '
Isikhathi Sokuposa: 2023 - 05 - 29 10:30:2:25
